ATLAS CAPITAL ADVISORS LLC - CORTEXYME INC ownership

CORTEXYME INC's ticker is CRTX and the CUSIP is 22053A107. A total of 41 filers reported holding CORTEXYME INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ATLAS CAPITAL ADVISORS LLC ownership history of CORTEXYME INC
ValueSharesWeighting
Q3 2021$274,980,000
+72.9%
3,0000.0%0.04%
+63.0%
Q2 2021$159,000,000
+47.1%
3,0000.0%0.03%
+28.6%
Q1 2021$108,090,000
-22.2%
3,0000.0%0.02%
-36.4%
Q2 2020$138,900,000
+1.5%
3,0000.0%0.03%
-19.5%
Q1 2020$136,830,000
-18.8%
3,0000.0%0.04%
-2.4%
Q4 2019$168,420,000
+350.4%
3,000
+100.0%
0.04%
+281.8%
Q3 2019$37,395,000
-41.4%
1,5000.0%0.01%
-47.6%
Q2 2019$63,765,0001,5000.02%
Other shareholders
CORTEXYME INC shareholders Q3 2023
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 4,079,461$20,001,0005.47%
Burleson & Company, LLC 224,599$1,390,0000.22%
PDT Partners, LLC 363,875$2,252,0000.19%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 325,000$2,012,0000.17%
Quantamental Technologies LLC 12,597$78,0000.04%
COHEN LAWRENCE B 11,126$69,0000.04%
Burleson & Company, LLC 242,200$240,0000.04%
Alphabet Inc. 189,122$1,169,0000.04%
Virtus ETF Advisers LLC 13,657$85,0000.04%
Hennion & Walsh Asset Management, Inc. 84,503$523,0000.03%
View complete list of CORTEXYME INC shareholders